Global Health Stock Price Analysis and Quick Research Report. Is Global Health an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Global Health. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Global Health has a PE ratio of 83.2440648956606 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Global Health has ROA of 9.1227% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Global Health has a Current ratio of 2.8001.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Global Health has a ROE of 14.1356%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Global Health has a Debt to Equity ratio of 0.0402 which means that the company has low proportion of debt in its capital.

• Sales growth: Global Health has reported revenue growth of 7.7124% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Global Health for the current financial year is 23.3050553876134%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Global Health is Rs 0.5 and the yield is 0.036%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Global Health is Rs 16.7099. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Global Health in Ticker for free. Also, one can get the intrinsic value of Global Health by using Valuation Calculators, which are available with a Finology ONE subscription. 

Global Health FAQs

Q1. What is Global Health share price today?
Ans: The current share price of Global Health is Rs 1391.

Q2. What is the market capitalisation of Global Health?
Ans: Global Health has a market capitalisation of Rs 37388.7421362 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Global Health?
Ans: The PE ratio of Global Health is 83.2440648956606 and the P/B ratio of Global Health is 10.2198930107246, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Global Health share?
Ans: The 52-week high share price of Global Health is Rs 1456.5, and the 52-week low share price of Global Health is Rs 935.5.

Q5. Does Global Health pay dividends?
Ans: Currently, Global Health pays dividends. Dividend yield of Global Health is around 0.036%.

Q6. What are the face value and book value of Global Health shares?
Ans: The face value of Global Health shares is Rs 2, while the book value per share of Global Health is around Rs 136.1071. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Global Health?
Ans: Global Health has a total debt of Rs 140.442 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Global Health?
Ans: The ROE of Global Health is 14.1356% and ROCE of Global Health is 19.2503%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Global Health a good buy for the long term?
Ans: The Global Health long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Global Health undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Global Health appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Global Health’s financials?
Ans: You can review Global Health’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.